Live Oak Health Sciences Fund LOGSX

Morningstar Medalist Rating
  • NAV / 1-Day Return$28.51  /  +0.32%
  • Fund Size$73.1M
  • Adjusted Expense Ratio1.040%
  • Net Expense Ratio1.040%
  • Fee Level: DistributionAbove Average
  • Share Class TypeInstitutional
  • Morningstar CategoryHealth
  • Equity Style Box (Funds)Mid Value
  • Minimum Initial Investment$2,000
  • Investment StatusOpen
  • TTM Yield0.08%
  • Turnover Ratio24%

Morningstar’s Analysis LOGSX

Will LOGSX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Live Oak Health Sciences holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings LOGSX

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings45.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Prime 3.53 10/1/26

6.204M
—

Cardinal Health Inc

5.223M
Healthcare

Exelixis Inc

5.033M
Healthcare

United Therapeutics Corp

4.933M
Healthcare

Amgen Inc

4.903M
Healthcare

Jazz Pharmaceuticals PLC

4.873M
Healthcare

Lantheus Holdings Inc

4.303M
Healthcare

McKesson Corp

4.173M
Healthcare

Regeneron Pharmaceuticals Inc

4.062M
Healthcare

Cencora Inc

3.962M
Healthcare

Sponsor Center